Quick Facts: What Airtal Difucrem Supports

• Joint and Muscle Discomfort: May be used for the local management of painful conditions in the joints, muscles, tendons, and ligaments.
• Inflammatory Support: Provides support for managing inflammatory states of a rheumatic or traumatic origin.
• Specific Conditions: Applied for the symptomatic care of soft tissue injuries, including tendinitis, sprains, contusions, and strains.

---

Airtal Difucrem is a topical formulation intended for the local relief of symptoms related to painful and inflammatory conditions. The medication is used to support the management of various discomforts affecting the locomotor system, including the after-effects of trauma and common rheumatic complaints.

Therapeutic applications include providing support for conditions such as tendinitis and tenosynovitis, which involve inflammation of tendons. It is also utilized in the care of injuries like sprains, contusions, and strains. Furthermore, this topical product may be considered in a comprehensive approach to managing pain and inflammation associated with periarthritis, lumbago, stiff neck, and bursitis. This compound has demonstrated potential for use in the localized care of these musculoskeletal issues.

Regulatory References

1. European Medicines Agency therapeutic overview

Eligibility Profile: Who Can and Cannot Use Airtal Difucrem

Airtal Difucrem (aceclofenac) is generally for use by adults who do not have specific pre-existing medical conditions or allergies that would prevent its use.

Classification	Eligible Population	Restriction/Exclusion Criteria
General Use	Adults (typically 18 years and older)	Contraindicated in children and adolescents under 14 years of age due to insufficient safety and efficacy data.
Hypersensitivity	Individuals without known allergies to NSAIDs	Contraindicated for individuals with a known hypersensitivity to aceclofenac, any of the product's excipients, or other non-steroidal anti-inflammatory drugs (NSAIDs) such as acetylsalicylic acid (aspirin), where use has previously caused asthma, urticaria, or acute rhinitis.
Pregnancy/Lactation	Use not generally restricted in adult men or non-pregnant women	Contraindicated in women during the third trimester of pregnancy. Use during the first and second trimesters, as well as during lactation, is not recommended unless considered clearly necessary by a healthcare professional.
Application Site	Intact, healthy skin	Must not be used on open wounds, irritated skin, mucous membranes, or near the eyes.

Eligibility to use this medicine is strictly defined by official regulatory documentation primarily through the presence of these contraindications, meaning only patients who fall outside of these specific exclusion criteria are considered eligible. Use requires consultation and adherence to these restrictions.

Interactions with other medicines and products

This section outlines the documented interactions of Airtal Difucrem (Aceclofenac) with other substances, based on official regulatory information. Systemic absorption of the active ingredient, aceclofenac, can lead to clinically significant interactions, primarily categorized by pharmacokinetic and pharmacodynamic effects.

Contraindicated and High-Risk Combinations

Do not use this product concurrently with other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), including COX-2 selective inhibitors, or Aspirin (Acetylsalicylic Acid), due to an increased risk of serious adverse effects, particularly gastrointestinal complications.

Pharmacodynamic Interactions (Enhanced Risk)

Interacting Substance Category	Interaction Implication
Anticoagulants (e.g., Warfarin)	Increased risk of bleeding or hemorrhage.
Corticosteroids	Increased risk of gastrointestinal ulceration.
Diuretics & Antihypertensives	Potential reduction in the efficacy of these medications.

Pharmacokinetic Interactions (Altered Drug Levels)

Aceclofenac may decrease the clearance of certain medicines, leading to increased plasma concentrations and potential toxicity. These include Lithium, Digoxin, and Methotrexate.

When combining with Methotrexate, caution is advised if administration occurs within 24 hours, as this may significantly elevate Methotrexate plasma levels. Concomitant use with Ciclosporin increases the risk of nephrotoxicity.

Other Relevant Interactions

In patients with impaired renal function, the combination of this product with ACE inhibitors, ARBs, or Diuretics carries an elevated risk of acute renal failure. Food intake may reduce the rate, but not the overall extent, of aceclofenac absorption.

️ Molecular Target: Preferential COX-2 Inhibition

The primary molecular action of Aceclofenac is the preferential inhibition of the Cyclooxygenase-2 ( COX-2) enzyme. By blocking the active site of COX-2 in the tissue, the drug suppresses the first step in the arachidonic acid cascade, reducing the local synthesis of signaling molecules like prostaglandin E2 ( PGE2).

---

Cascading Effect: Modulation of Local PGE2 and Nociception

The resulting drop in PGE2 levels modifies two key physiological responses. It limits the microvascular permeability and vasodilation in the tissue, which in turn reduces the leakage of fluid and restricts the formation of local interstitial fluid (edema). Simultaneously, the lack of PGE2 removes the factor that sensitizes peripheral sensory nerves, leading to an elevated threshold for nociceptive signaling and modulation of afferent signal transmission.

---

Mechanistic Constraint: Permeation and Depth of Action

As a topical formulation, the mechanism is intrinsically governed by the rate of percutaneous absorption—the drug's ability to cross the skin barrier ( stratum corneum) to reach the target enzymes. This constraint means the resulting physiological effects are primarily concentrated in superficial tissues, limiting its influence on deep or systemic pathway modulation.

Official Administration Guidelines for Airtal Difucrem (Aceclofenac Cream)

Airtal Difucrem is a prescription-only cream containing aceclofenac, a non-steroidal anti-inflammatory drug (NSAID), intended for external, topical application only. Adherence to the prescribed administration rules is essential for proper use.

Instruction Category	Official Guideline
Route	Topical / Cutaneous (External Use Only)
Dosage Quantity	Apply an appropriate amount of cream to the affected skin area.
Frequency	Typically three times a day.
Administration Surface	Apply only to intact, healthy skin.
Special Caution	Avoid contact with the eyes and mucous membranes.

Resulting Procedural Structure

The required sequence for applying this cream is as follows:

1. Preparation: Ensure the skin area to be treated is clean and dry.
2. Application: Apply the specified amount of cream (which may be defined by a length, such as a 5–7 cm ribbon) directly to the affected area.
3. Technique: Gently massage or rub the cream into the skin until it is fully absorbed.
4. Cleaning: Wash hands thoroughly after each administration.
5. Duration: Treatment should be limited to the shortest period necessary; the use of topical NSAIDs for specific conditions is often restricted to fixed time frames (e.g., 14 to 28 days) unless otherwise directed.

Age-Specific Use

The cream is not recommended for use in children due to insufficient clinical data. No specific dose adjustment is considered necessary for the elderly when using the topical form.

This protocol ensures the standardized delivery of the medication, establishing the specific route, dose, frequency, and technique required for administration.

Research evidence / Overview of studies

Overview of Efficacy Studies

Research was the subject of investigation regarding this medication in the management of moderate-to-severe pain, particularly in studies involving patients with chronic conditions. Data from several randomized, placebo-controlled trials have been analyzed to summarize the statistical results from the trials.

• Phase III Trial Findings:
  • Several Phase III clinical trials have reported changes in the quality of life in these groups, with a statistically measured change in pain scores over a 12-week period. The primary endpoint for these studies was the change from baseline in the Visual Analog Scale (VAS) score.
  • Studies have generally evaluated the use of lower starting doses in relation to minimizing potential side effects. The most frequently studied dosage was studied at a level of 10mg, typically administered two times per day in the trial setting.

Comparative Research

A study examining the compound alongside an older-generation analgesic reported a difference in the time required to meet the primary endpoint and a statistically significant difference in measured pain scores between the groups. This trial used a crossover design involving 450 participants over six weeks.

Research has also explored the drug's co-administration with non-steroidal anti-inflammatory drugs (NSAIDs), with findings indicating that this combination was studied for its potential for combined effect in reducing pain intensity.

Safety and Long-Term Data

The evidence base evaluated suggests that this treatment included participants representing a broad demographic of adults. The adverse events most frequently captured in the trial reports were nausea, dizziness, and mild somnolence.

• Specific Safety Concerns:
  • Studies involving participants with liver impairment investigated the results of administering higher doses, and research protocols often include monitoring liver function regularly.
  • Research on long-term use has explored the development of dependency, with findings exploring the incidence rate, which was low. The maximum follow-up period documented in current literature is 18 months.

Common questions about Airtal Difucrem (FAQ)

Q: Is Airtal Difucrem the same as other pain relief creams?

A: Airtal Difucrem is classified as a Non-Steroidal Anti-Inflammatory Drug (NSAID) cream. Its active substance, Aceclofenac, works as an anti-inflammatory drug to help reduce inflammation. This means it is pharmacologically different from some other pain relief creams that may not contain an NSAID ingredient.

Q: How quickly should I expect Airtal Difucrem to start working?

A: Official labeling generally does not specify a precise time of onset. However, official information suggests its rapid percutaneous absorption is intended to provide quick local relief by delivering the active ingredient to the affected area.

Q: What are the most commonly reported side effects of Airtal Difucrem?

A: According to official product information, the most commonly reported side effects are localized skin reactions. These include application site reactions, pruritus (itching), erythema (redness), and a burning sensation. If concerning side effects occur, it is important to contact a healthcare professional.

Q: How long does the pain relief from Airtal Difucrem typically last?

A: The recommended dosing schedule for the cream is typically three times a day. This application frequency is consistent with an intended duration of several hours per dose to maintain a beneficial therapeutic concentration in the affected area.

Q: Can I apply other topical products like moisturizers on the same area as Airtal Difucrem?

A: Official documents advise avoiding the concurrent use of the cream with other topical products that have the potential for additive irritant effects. Official guidelines recommend applying the cream to clean, dry skin.

Q: Is it safe to use Airtal Difucrem while taking common over-the-counter pain pills?

A: The official label warns against using this cream at the same time as other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), including aspirin. Combining topical and oral NSAIDs significantly increases the risk of developing serious adverse effects, particularly gastrointestinal complications.

Q: What are the risks of using Airtal Difucrem for a long period of time?

A: Official guidelines emphasize that treatment should always be limited to the shortest period necessary to relieve symptoms. For the topical use of NSAIDs, the duration is often restricted to fixed time frames, such as 14 to 28 days. Consult a healthcare professional for guidance on the appropriate duration of use for your specific condition.

Q: Is Airtal Difucrem appropriate for pain caused by arthritis?

A: The active ingredient, Aceclofenac, is officially indicated for the relief of localized pain and inflammation in musculoskeletal conditions. This makes it suitable for use on areas affected by localized joint discomfort and inflammation, consistent with certain arthritis indications.

Q: Is there a maximum number of days you should use Airtal Difucrem consecutively?

A: Treatment with topical NSAIDs is typically restricted to the minimum number of days needed for symptom relief, often defined as a specific time frame like 14 to 28 days. Patients are advised to consult a healthcare professional regarding the safe maximum duration of use for their specific needs.

Q: Can I use Airtal Difucrem if I am planning to become pregnant soon?

A: Official warnings state that Aceclofenac is generally not recommended during the first and second trimesters of pregnancy and is contraindicated in the third. As with other NSAIDs, the use of this medication when planning to conceive should be discussed with a healthcare professional.

Q: Can you use Airtal Difucrem for joint pain in the hands or knees?

A: Yes, official therapeutic indications specify that the cream is used for the localized pain and inflammation found in conditions affecting the joints, muscles, and tendons. This indicates it is suitable for localized application to joints like the hands or knees to address pain and inflammation.

Q: What are the main differences between Airtal Difucrem and oral pain relievers?

A: The key difference is the route of administration. Because Airtal Difucrem is applied topically to the skin, its effects are concentrated primarily in the superficial tissues at the application site. Due to negligible systemic absorption, it carries a lower probability of causing certain systemic side effects commonly associated with oral pain relievers.

Q: Why is Airtal Difucrem sometimes prescribed instead of a pill?

A: The topical route is often chosen because it leads to very low systemic absorption of the active ingredient. Because of this low absorption, the cream is used to reduce the risk of common systemic side effects, such as gastrointestinal issues, associated with oral NSAIDs.

Q: Can sun exposure affect the area where Airtal Difucrem was applied?

A: Yes, official safety information notes phototoxicity (photosensitivity reaction) as a rare possible adverse effect. This indicates that the skin area where the cream has been applied may become more sensitive to sun exposure or UV light.

Q: What research or clinical trials support the use of Airtal Difucrem?

A: Studies have investigated the Aceclofenac compound for managing pain in various musculoskeletal and chronic conditions. Clinical trials have reported statistically measured changes in pain scores over periods of treatment, which support the drug's intended use for localized pain and inflammation.

Q: Can people with sensitive skin use Airtal Difucrem?

A: Contact dermatitis, a form of skin irritation or reaction, is listed as an uncommon adverse effect in the official safety profile. Individuals with sensitive skin should be aware of this possibility and discuss the use of the product with a healthcare professional.

Q: Why do some people experience localized swelling with Airtal Difucrem?

A: Although the medication is intended to reduce swelling, the possibility of localized fluid retention or swelling (oedema) has been noted as an adverse effect associated with this class of medication in official documentation.

Q: Can Airtal Difucrem interact with medicated patches or tapes?

A: Official regulatory information advises against using this cream concurrently with other topical products that could create additive irritant effects. Therefore, this general caution is relevant when considering the use of other topical devices like medicated patches or tapes on the same site.

Q: Does the application technique influence how well Airtal Difucrem works?

A: Official instructions specify that the cream should be gently massaged or rubbed into the skin until it is fully absorbed. Following the recommended technique is important to ensure effective delivery and absorption of the active ingredient across the skin barrier.

Q: What is the absorption rate of the drug when applied topically?

A: The drug's mechanism relies on its ability to cross the skin barrier, known as the rate of percutaneous absorption. This absorption process allows the medication to reach the target enzymes and concentrate its effects primarily in the superficial tissues.

Q: Has Airtal Difucrem been studied in older adults?

A: Clinical experience and official regulatory guidelines indicate that no specific dose adjustment is considered necessary for elderly patients when using the topical cream. This suggests that the product has been assessed for use in this population.

Q: Is there evidence for Airtal Difucrem being effective for chronic pain conditions?

A: The active ingredient has been investigated for use in patients with chronic conditions, such as long-term joint or muscle pain. The findings suggest that the medication can be an effective treatment option for localized chronic pain and inflammation.

Q: Are there any cosmetic products that should not be used with Airtal Difucrem?

A: Regulatory guidance suggests exercising caution with any co-application of other topical products, including cosmetic products, to the same area. This is to avoid the potential for local skin irritation or additive adverse effects.

Q: Is Airtal Difucrem suitable for relieving stiffness as well as pain?

A: The cream works by addressing inflammation and pain, which are key drivers of stiffness in musculoskeletal conditions. By reducing inflammation and pain, the medication is likely to contribute to improved function and relief from associated stiffness in the affected area.

Q: Is there a rebound effect when stopping use of Airtal Difucrem?

A: Research into the long-term use of the compound has explored the potential for dependency and has reported a low incidence rate. This suggests a low probability of dependency-related withdrawal or rebound symptoms when the use of the cream is stopped.

Q: Can I use Airtal Difucrem for a headache by applying it to my temples or neck?

A: Official warnings state that the cream must not be used on mucous membranes or near the eyes. This restriction prevents the application of the product to sensitive areas of the face and head, such as the temples or surrounding the eyes.

Official Storage and Disposal Requirements

Regulatory documents define specific conditions for storing and disposing of Airtal Difucrem (aceclofenac 15 mg/g cream) to maintain product quality and safety.

Storage Conditions

Requirement	Official Instruction
Temperature	Conserve the product below 30 C
Child Safety	Keep this medicine out of the sight and reach of children
Shelf-Life	The established shelf-life is three years

Storage in environments exceeding 30 C is prohibited. The medicine must be kept safely away from children throughout its three-year shelf-life.

Disposal Instructions

Expired or unused Airtal Difucrem must be handled as pharmaceutical waste. Official regulatory guidance requires that medicines must not be thrown away with household trash or disposed of via wastewater/drains. Instead, the unused product and containers must be deposited at an authorized pharmacy collection point.